Medicines Act Notices




2 SEPTEMBER NEW ZEALAND GAZETTE 2601

recited and do openly and publicly pronounce and declare that the same ought so to remain separated and dedicated and consecrated accordingly.

In testimony whereof we have subscribed this sentence of consecration on this the fourth day October in the year of Our Lord one thousand eight hundred and sixty nine and in the fourteenth year of our Consecration.

HIC Christchurch


Medicines Act 1981

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Air Salonpas.

Active Ingredient(s): Methyl salicylate 0.0175 g/mL.
Menthol 0.032 g/mL.
Camphor 0.03 g/mL.

Dosage Form: Topical spray.

NZ Sponsor: Pharmacare (NZ) Limited.

Manufacturer(s): Hisamitsu Pharmaceutical Co Inc, Tosu, Saga, Japan.

Dated this 30th day of August 1999.

G. R. BOYD,
Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).


Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the act and are set out in the Schedule hereto:

Schedule

Product: Naropin.

Active Ingredient(s): Ropivacaine hydrochloride (monohydrate) 10 mg/mL.

Dosage Form: Solution for injection.

NZ Sponsor: AstraZeneca Limited.

Manufacturer(s): Astra Pharmaceutical Production AB, Södertälje, Sweden.
Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia.

Product: Naropin.

Active Ingredient(s): Ropivacaine hydrochloride (monohydrate) 2 mg/mL.

Dosage Form: Solution for injection.

NZ Sponsor: AstraZeneca Limited.

Manufacturer(s): Astra Pharmaceutical Production AB, Södertälje, Sweden.
Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia.

Product: Naropin.

Active Ingredient(s): Ropivacaine hydrochloride (monohydrate) 7.5 mg/mL.

Dosage Form: Solution for injection.

NZ Sponsor: AstraZeneca Limited.

Manufacturer(s): Astra Pharmaceutical Production AB, Södertälje, Sweden.
Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia.

Product: Ogen.

Active Ingredient(s): Piperazine oestrone sulphate 0.75 mg.

Dosage Form: Tablet.

NZ Sponsor: Pharmacia & Upjohn.

Manufacturer(s): Abbott Health Products, Pharmaceutical Products Plant, Cruce Davila, Barceloneta, Spain.



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1999, No 108


NZLII PDF NZ Gazette 1999, No 108





✨ LLM interpretation of page content

🏥 Consecration of Cemetery Land in Mandeville District

🏥 Health & Social Welfare
Consecration, Cemetery, Church of England, Mandeville District, Canterbury

🏥 Consent to the Distribution of a New Medicine

🏥 Health & Social Welfare
30 August 1999
Medicines Act, New Medicine, Air Salonpas, Methyl salicylate, Menthol, Camphor, Topical spray, Pharmacare (NZ) Limited, Hisamitsu Pharmaceutical Co Inc
  • G. R. Boyd, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997)

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
Medicines Act, Changed Medicines, Naropin, Ropivacaine hydrochloride, Solution for injection, AstraZeneca Limited, Ogen, Piperazine oestrone sulphate, Tablet, Pharmacia & Upjohn